Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biochem Mol Toxicol ; 34(11): e22580, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32662911

RESUMEN

Valproic acid (VPA) is an effective drug, which is preferred for the treatments of epilepsy and various kinds of seizures. Nonetheless, VPA has many life-threatening side effects associated with free radical production. Alpha-lipoic acid (ALA) is a powerful antioxidant, which can scavenge reactive oxygen species (ROS). The effects of ALA against VPA-stimulated brain injury were investigated. In this study, Sprague-Dawley rats were divided as four groups: Group I, control rats; Group II, ALA-administered rats (50 mg/kg/d); Group III, VPA-administered rats (0.5 g/kg/d); Group IV: VPA- and ALA-administered rats at the same dose and time. According to the results, VPA increased lipid peroxidation, protein carbonyl, advanced oxidation protein products, total oxidant status, nitric oxide levels and glutathione-S-transferase, adenosine deaminase, xanthine oxidase activities, decreased glutathione, total antioxidant capacity levels, catalase, superoxide dismutase, glutathione peroxidase, sodium-potassium ATPase, and paraoxonase activities. Treatment with ALA reversed these effects. In conclusion, we may suggest that ALA may be a good candidate for prevention of VPA-induced brain injury.


Asunto(s)
Lesiones Encefálicas/prevención & control , Ácido Tióctico/farmacología , Ácido Valproico/farmacología , Animales , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Ácido Tióctico/administración & dosificación , Ácido Valproico/administración & dosificación
2.
Biosci Biotechnol Biochem ; 73(2): 260-7, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19202268

RESUMEN

This study was designed to determine the morphological and biochemical effects of zinc sulfate and the role of metallothionein in ethanol-induced intestinal injury. Rats received zinc sulfate (100 mg/kg/d) for 3 consecutive d, 2 h prior to the administration of ethanol by gavage. Ethanol administration caused intestinal injury as determined by increased serum lactate dehydrogenase activity, urea, creatinine, uric acid, and sialic acid levels, intestinal lipid peroxidation level, decreased serum catalase activity, intestinal glutathione level, and metallothionein expression. Zinc sulfate pretreatment of the ethanol group caused a decrease in histological damage, serum lactate dehydrogenase activity, urea, creatinine, uric acid, sialic acid levels, and intestinal lipid peroxidation level, but increases in serum catalase activity, intestinal glutathione level, and metallothionein expression. The present study indicates that zinc sulfate has a protective effect against ethanol-induced intestinal injury. In addition, the protective effect of zinc on ethanol-induced intestinal injury might be mediated by metallothionein, as well as having antioxidative potential.


Asunto(s)
Etanol/administración & dosificación , Etanol/toxicidad , Intestinos/efectos de los fármacos , Intestinos/lesiones , Suero/metabolismo , Sulfato de Zinc/farmacología , Animales , Catalasa/sangre , Catalasa/metabolismo , Inmunohistoquímica , Mucosa Intestinal/metabolismo , L-Lactato Deshidrogenasa/sangre , L-Lactato Deshidrogenasa/metabolismo , Masculino , Metalotioneína/metabolismo , Ratas , Ratas Wistar , Suero/enzimología
3.
Drug Chem Toxicol ; 31(4): 413-26, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18850353

RESUMEN

The aim of this study was to determine whether vitamin C, vitamin E, and selenium have protective effects against cadmium-induced renal toxicity of rats. Vitamin C (250 mg/kg/day), vitamin E (250 mg/kg/day), and sodium selenate (0.25 mg/kg/day) were given to rats orally for 8 days. Cadmium (2 mg/kg/day CdCl2) was given to rats intraperitoneally. Vitamin C, vitamin E, and selenium (in the same dose and time) were given 1 h prior to the administration of cadmium every day. The tissue and blood samples were taken from the rats for histological evaluation and biochemical analyses on the Day 9. Lipid peroxidation (LPO) and glutathione (GSH) determination were made in kidney tissue. In addition, urea and creatinine levels were determined in serum. The damage to the kidney tissue was moderate in the rats given cadmium. In this group, the distinctive changes in the proximal tubules were observed. Degenerative changes in kidney tissue were also observed in rats given vitamin C, vitamin E, selenium, and cadmium. LPO levels significantly increased and GSH levels decreased in kidney tissues following cadmium administration. Serum urea and creatinine levels were also increased in rats given cadmium. The administration of vitamin C, vitamin E, and selenium caused a significant decrease in LPO levels and an increase in GSH levels in the kidney of rats given cadmium. Serum urea and creatinine levels were decreased in rats given both the antioxidant and cadmium. It is concluded that vitamin C, vitamin E, and selenium showed some protective effect on the rat kidney.


Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Enfermedades Renales/prevención & control , Riñón/efectos de los fármacos , Compuestos de Selenio/farmacología , Vitamina E/farmacología , Administración Oral , Animales , Antioxidantes/administración & dosificación , Ácido Ascórbico/administración & dosificación , Cloruro de Cadmio , Creatinina/sangre , Citoprotección , Modelos Animales de Enfermedad , Glutatión/metabolismo , Riñón/metabolismo , Riñón/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratas , Ratas Sprague-Dawley , Ácido Selénico , Compuestos de Selenio/administración & dosificación , Urea/sangre , Vitamina E/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA